Abstract Background Cisplatin (DDP) resistance has long posed a challenge in the clinical treatment of lung cancer (LC). Insulin-like growth factor 2 binding protein 2 (IGF2BP2) has been identified as an oncogenic factor in LC. whereas its specific role in DDP resistance in LC remains unclear. Results In this study. https://www.diegojavierfares.com/quick-offer-Little-Ollie-174-Dwarf-Olive-Monrovia-super-sale/